160 related articles for article (PubMed ID: 24395226)
21. Nanoscale effects of caspofungin against two yeast species, Saccharomyces cerevisiae and Candida albicans.
Formosa C; Schiavone M; Martin-Yken H; François JM; Duval RE; Dague E
Antimicrob Agents Chemother; 2013 Aug; 57(8):3498-506. PubMed ID: 23669379
[TBL] [Abstract][Full Text] [Related]
22. Identification of New Antifungal Agents Targeting Chitin Synthesis by a Chemical-Genetic Method.
Li Y; Sun H; Zhu X; Bian C; Wang Y; Si S
Molecules; 2019 Aug; 24(17):. PubMed ID: 31470665
[TBL] [Abstract][Full Text] [Related]
23. Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.
Arendrup MC; Perkhofer S; Howard SJ; Garcia-Effron G; Vishukumar A; Perlin D; Lass-Flörl C
Antimicrob Agents Chemother; 2008 Oct; 52(10):3504-11. PubMed ID: 18644959
[TBL] [Abstract][Full Text] [Related]
24. Nanoscopic cell-wall architecture of an immunogenic ligand in Candida albicans during antifungal drug treatment.
Lin J; Wester MJ; Graus MS; Lidke KA; Neumann AK
Mol Biol Cell; 2016 Mar; 27(6):1002-14. PubMed ID: 26792838
[TBL] [Abstract][Full Text] [Related]
25. Aspergillus fumigatus devoid of cell wall β-1,3-glucan is viable, massively sheds galactomannan and is killed by septum formation inhibitors.
Dichtl K; Samantaray S; Aimanianda V; Zhu Z; Prévost MC; Latgé JP; Ebel F; Wagener J
Mol Microbiol; 2015 Feb; 95(3):458-71. PubMed ID: 25425041
[TBL] [Abstract][Full Text] [Related]
26. Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B.
Sandovsky-Losica H; Shwartzman R; Lahat Y; Segal E
J Antimicrob Chemother; 2008 Sep; 62(3):635-7. PubMed ID: 18490373
[No Abstract] [Full Text] [Related]
27. SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies.
Scorneaux B; Angulo D; Borroto-Esoda K; Ghannoum M; Peel M; Wring S
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069658
[TBL] [Abstract][Full Text] [Related]
28. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.
Wheeler RT; Kombe D; Agarwala SD; Fink GR
PLoS Pathog; 2008 Dec; 4(12):e1000227. PubMed ID: 19057660
[TBL] [Abstract][Full Text] [Related]
29. A drug-sensitive genetic network masks fungi from the immune system.
Wheeler RT; Fink GR
PLoS Pathog; 2006 Apr; 2(4):e35. PubMed ID: 16652171
[TBL] [Abstract][Full Text] [Related]
30. Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.
Satish S; Jiménez-Ortigosa C; Zhao Y; Lee MH; Dolgov E; Krüger T; Park S; Denning DW; Kniemeyer O; Brakhage AA; Perlin DS
mBio; 2019 Jun; 10(3):. PubMed ID: 31164462
[No Abstract] [Full Text] [Related]
31. Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Kovács R; Nagy F; Tóth Z; Bozó A; Balázs B; Majoros L
Lett Appl Microbiol; 2019 Oct; 69(4):271-278. PubMed ID: 31385615
[TBL] [Abstract][Full Text] [Related]
32. Rapid redistribution of phosphatidylinositol-(4,5)-bisphosphate and septins during the Candida albicans response to caspofungin.
Badrane H; Nguyen MH; Blankenship JR; Cheng S; Hao B; Mitchell AP; Clancy CJ
Antimicrob Agents Chemother; 2012 Sep; 56(9):4614-24. PubMed ID: 22687514
[TBL] [Abstract][Full Text] [Related]
33. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1.
Marakalala MJ; Vautier S; Potrykus J; Walker LA; Shepardson KM; Hopke A; Mora-Montes HM; Kerrigan A; Netea MG; Murray GI; Maccallum DM; Wheeler R; Munro CA; Gow NA; Cramer RA; Brown AJ; Brown GD
PLoS Pathog; 2013; 9(4):e1003315. PubMed ID: 23637604
[TBL] [Abstract][Full Text] [Related]
34. Changes in cell wall synthesis and ultrastructure during paradoxical growth effect of caspofungin on four different Candida species.
Bizerra FC; Melo AS; Katchburian E; Freymüller E; Straus AH; Takahashi HK; Colombo AL
Antimicrob Agents Chemother; 2011 Jan; 55(1):302-10. PubMed ID: 21060107
[TBL] [Abstract][Full Text] [Related]
35. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of beta-D-1,3 glucan levels in culture.
Kahn JN; Hsu MJ; Racine F; Giacobbe R; Motyl M
Antimicrob Agents Chemother; 2006 Jun; 50(6):2214-6. PubMed ID: 16723587
[TBL] [Abstract][Full Text] [Related]
36. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro.
Bowman JC; Hicks PS; Kurtz MB; Rosen H; Schmatz DM; Liberator PA; Douglas CM
Antimicrob Agents Chemother; 2002 Sep; 46(9):3001-12. PubMed ID: 12183260
[TBL] [Abstract][Full Text] [Related]
37. Highly Dynamic and Specific Phosphatidylinositol 4,5-Bisphosphate, Septin, and Cell Wall Integrity Pathway Responses Correlate with Caspofungin Activity against Candida albicans.
Badrane H; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2016 Jun; 60(6):3591-600. PubMed ID: 27021331
[TBL] [Abstract][Full Text] [Related]
38. In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.
Ganesan LT; Manavathu EK; Cutright JL; Alangaden GJ; Chandrasekar PH
Clin Microbiol Infect; 2004 Nov; 10(11):961-6. PubMed ID: 15521997
[TBL] [Abstract][Full Text] [Related]
39. Synergy of the antibiotic colistin with echinocandin antifungals in Candida species.
Zeidler U; Bougnoux ME; Lupan A; Helynck O; Doyen A; Garcia Z; Sertour N; Clavaud C; Munier-Lehmann H; Saveanu C; d'Enfert C
J Antimicrob Chemother; 2013 Jun; 68(6):1285-96. PubMed ID: 23378416
[TBL] [Abstract][Full Text] [Related]
40. Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity.
Plaine A; Walker L; Da Costa G; Mora-Montes HM; McKinnon A; Gow NA; Gaillardin C; Munro CA; Richard ML
Fungal Genet Biol; 2008 Oct; 45(10):1404-14. PubMed ID: 18765290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
